Xeris Biopharma Holdings, Inc. (LON: 0A8E)
London
· Delayed Price · Currency is GBP · Price in USD 3.330
-0.009 (-0.28%)
Jan 22, 2025, 5:09 PM BST
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of 398.24 million as of January 23, 2025. Its market cap has increased by 49.90% in one year.
Market Cap
398.24M
Enterprise Value
561.90M
Revenue
139.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.33
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from 218.21M to 398.24M, an increase of 82.51%. That is a compound annual growth rate of 20.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2025 | 398.24M | -1.35% |
| Dec 31, 2024 | 403.69M | 58.41% |
| Dec 29, 2023 | 254.83M | 69.77% |
| Dec 30, 2022 | 150.10M | -44.38% |
| Dec 31, 2021 | 269.85M | 23.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.37B |
| GSK plc | 55.25B |
| Haleon | 33.81B |
| Smith & Nephew | 8.96B |
| ConvaTec Group | 4.94B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 1.99B |
| Oxford Nanopore Technologies | 1.42B |